top of page
  • Critical Innovations

Successful porcine safety trial of the F.O.A.M.™ device published in Military Medicine

Severe intra-abdominal bleeding currently requires operative treatment by trained surgeons, while Critical Innovations' patented F.O.A.M.™ technology task-shifts to allow earlier abdominal hemostasis by a wider range of providers. A recent article in Military Medicine evaluated the characteristics, survival, and histological analysis of using the F.O.A.M.™ device in a porcine model. In the study, F.O.A.M.™ reached the desired intra-abdominal pressure endpoint while not significantly altering basic hematologic parameters. These results provide strong support for the safety of the FOAM™ device and will support the design of further regulatory studies in swine and humans. See full article here.

33 views0 comments

Recent Posts

See All

Critical Innovations is happy to announce that it recently signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Chemical Biologica

Critical Innovations signed a new Cooperative Research and Development Agreement (CRADA) with the Naval Medical Center San Diego / Navy Medicine Readiness and Training Command San Diego. The company i

bottom of page